Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV(1)

BACKGROUND: The primary lung function endpoint in clinical trials in adolescent and adult patients with asthma is usually forced expiratory volume in one second (FEV(1)). The objective of our analysis was to assess whether peak expiratory flow (PEF) is a suitable alternative primary lung function en...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Respir Res
Egile Nagusiak: Halpin, David M. G., Meltzer, Eli O., Pisternick-Ruf, Wendelgard, Moroni-Zentgraf, Petra, Engel, Michael, Zaremba-Pechmann, Liliana, Casale, Thomas, FitzGerald, J. Mark
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6637596/
https://ncbi.nlm.nih.gov/pubmed/31319851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-019-1119-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak